SEC Company Response from TuHURA Biosciences, (HURA) — May 14, 2015
TuHURA Biosciences, Inc./NV (HURA) (CIK 0001498382)
Date: May 14, 2015 · CIK: 0001498382 · Accession: 0001013762-15-000490
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-203357
Referenced dates: May 12, 2015
Letter
DelMar Pharmaceuticals, Inc.
Suite 720-999 West Broadway
Vancouver, British Columbia
Canada V5Z 1K5
May 14,
EDGAR
Division of Corporation Finance
Securities and Exchange Commission
100 F Street, N.E.
Washington, D.C. 20549
Re: DelMar Pharmaceuticals, Inc.
Registration Statement on Form S-1
File No. 333-203357
Ladies and Gentlemen:
DelMar Pharmaceuticals, Inc. hereby requests withdrawal of its request for the acceleration of effectiveness of the above-referenced registration statement as set forth in its letter dated May 12, 2015.
DelMar Pharmaceuticals, Inc.
By: /s/ Jeffrey Bacha
Name: Jeffrey Bacha Title: Chief Executive Officer
Show Raw Text
CORRESP
1
filename1.htm
DelMar Pharmaceuticals, Inc.
Suite 720-999 West Broadway
Vancouver, British Columbia
Canada V5Z 1K5
May 14,
2015
EDGAR
Division of Corporation Finance
Securities and Exchange Commission
100 F Street, N.E.
Washington, D.C. 20549
Re: DelMar Pharmaceuticals, Inc.
Registration Statement on Form S-1
File No. 333-203357
Ladies
and Gentlemen:
DelMar
Pharmaceuticals, Inc. hereby requests withdrawal of its request for the acceleration of effectiveness of the above-referenced registration
statement as set forth in its letter dated May 12, 2015.
DelMar
Pharmaceuticals, Inc.
By:
/s/ Jeffrey Bacha
Name: Jeffrey Bacha
Title:
Chief Executive Officer